Spero Therapeutics, Inc. (SPRO)
2.30
-0.02
(-0.86%)
USD |
NASDAQ |
Dec 29, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Spero Therapeutics Total Assets (Quarterly): 54.17M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Amicus Therapeutics, Inc. | 868.81M |
| Cassava Sciences, Inc. | 129.73M |
| Omeros Corp. | 185.71M |
| GeoVax Labs, Inc. | 6.731M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.68M |
| Shareholders Equity (Quarterly) | 26.49M |
| Debt to Equity Ratio | 0.1265 |
| Current Ratio | 3.834 |
| Net Debt Paydown Yield | 0.30% |